A Pilot Study to Evaluate ZADAXIN’s® (Thymalfasin) Ability to Enhance Immune Response to the H1N1sw Influenza Vaccine
Condition(s):END STAGE RENAL DISEASELast Updated:March 29, 2012Completed
Hide Studies Not Open or Pending
Condition(s):END STAGE RENAL DISEASELast Updated:March 29, 2012Completed
Condition(s):End Stage Renal DiseaseLast Updated:March 23, 2022Completed
Condition(s):Primary Biliary Cholangitis; Heart Failure; Digestive Diseases; Women Who Have Experienced a Cardiac Event; Cirrhosis, Liver; Post-Transplant; Cancer; Chronic Kidney Diseases; Other Chronic Physical ConditionLast Updated:March 7, 2024Recruiting
Condition(s):Chronic Renal Failure; Kidney Transplantation; Weight Gain; Insulin Resistance; DiabetesLast Updated:July 8, 2014Completed
Condition(s):End Stage Renal DiseaseLast Updated:May 13, 2013Completed
Condition(s):Cardiovascular Diseases; Heart Diseases; Hypertension; Kidney Failure, ChronicLast Updated:May 13, 2016Completed
Condition(s):Vitamin D Deficiency; End Stage Renal DiseaseLast Updated:February 8, 2024Completed
Condition(s):End-stage Renal Disease (ESRD)Last Updated:December 13, 2016Completed
Condition(s):End Stage Renal DiseaseLast Updated:May 13, 2013Completed
Condition(s):End Stage Renal DiseaseLast Updated:April 18, 2018Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.